kanamycin a has been researched along with pemetrexed in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, QR; Fang, F; Gong, HB; Li, DD; Li, JR; Pi, YZ; Sun, J; Zhong, WQ; Zhu, HL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for kanamycin a and pemetrexed
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for kanamycin a and pemetrexed
| Article | Year |
|---|---|
Novel 1,3,4-oxadiazole thioether derivatives targeting thymidylate synthase as dual anticancer/antimicrobial agents.
Topics: Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Escherichia coli; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Oxadiazoles; Quantitative Structure-Activity Relationship; Structure-Activity Relationship; Thermodynamics; Thymidylate Synthase | 2013 |